vida: research 2026 04 29 #5623

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 06:46:41 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 06:47 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 06:47 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points like MSSP savings and GLP-1 coverage declines, and the inbox files are source metadata, which are not subject to factual accuracy review.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the journal entry provides specific quantitative evidence from MSSP data to support the strengthening of this belief.
  4. Wiki links — There are no wiki links present in the research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points like MSSP savings and GLP-1 coverage declines, and the inbox files are source metadata, which are not subject to factual accuracy review. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the journal entry provides specific quantitative evidence from MSSP data to support the strengthening of this belief. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent working documents without schema requirements, so no schema violations exist in this PR.

  2. Duplicate/redundancy — The research journal synthesizes evidence from 11 new sources into a coherent disconfirmation analysis; without seeing the actual source files or existing claims being enriched, I cannot verify whether these sources inject duplicate evidence, but the journal entry itself presents a novel analytical synthesis (market competition vs. VBC structural reform) not redundant with prior sessions.

  3. Confidence — No claims are modified in this PR (only sources added and journal updated), so there are no confidence levels to evaluate.

  4. Wiki links — The journal references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims needing enrichment, but these are narrative references in a research journal, not broken wiki links in claim files; no actual broken wiki link syntax appears in the diff.

  5. Source quality — The sources cited (CMS MSSP reports, Health Affairs, 9amHealth industry analysis, MHPAEA reports, HCPlan VBC data) are authoritative primary sources and credible industry publications appropriate for healthcare policy claims.

  6. Specificity — No claims are being created or modified in this PR; the research journal contains falsifiable analytical statements (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be contradicted by evidence, demonstrating appropriate specificity for research documentation.

Verdict Reasoning

This PR adds sources to the inbox and updates Vida's research journal with a new analytical session. No claims are created or modified, so the primary evaluation criteria (schema for claims, confidence calibration, specificity) are not applicable. The research journal demonstrates rigorous disconfirmation methodology and cites credible sources. The analytical conclusions (VBC structural reform working, market competition marginal) are supported by quantitative evidence from authoritative sources. No schema violations, factual discrepancies, or other issues detected.

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent working documents without schema requirements, so no schema violations exist in this PR. 2. **Duplicate/redundancy** — The research journal synthesizes evidence from 11 new sources into a coherent disconfirmation analysis; without seeing the actual source files or existing claims being enriched, I cannot verify whether these sources inject duplicate evidence, but the journal entry itself presents a novel analytical synthesis (market competition vs. VBC structural reform) not redundant with prior sessions. 3. **Confidence** — No claims are modified in this PR (only sources added and journal updated), so there are no confidence levels to evaluate. 4. **Wiki links** — The journal references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims needing enrichment, but these are narrative references in a research journal, not broken [[wiki links]] in claim files; no actual broken wiki link syntax appears in the diff. 5. **Source quality** — The sources cited (CMS MSSP reports, Health Affairs, 9amHealth industry analysis, MHPAEA reports, HCPlan VBC data) are authoritative primary sources and credible industry publications appropriate for healthcare policy claims. 6. **Specificity** — No claims are being created or modified in this PR; the research journal contains falsifiable analytical statements (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be contradicted by evidence, demonstrating appropriate specificity for research documentation. ## Verdict Reasoning This PR adds sources to the inbox and updates Vida's research journal with a new analytical session. No claims are created or modified, so the primary evaluation criteria (schema for claims, confidence calibration, specificity) are not applicable. The research journal demonstrates rigorous disconfirmation methodology and cites credible sources. The analytical conclusions (VBC structural reform working, market competition marginal) are supported by quantitative evidence from authoritative sources. No schema violations, factual discrepancies, or other issues detected. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 06:48:02 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 06:48:02 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 06:50:38 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.